✦ LIBER ✦

P1196 ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS

✍ Scribed by Salmerón, J.; Pons, J.; Quiles, R.; Pascasio, J.; Carmona, I.; Simón, M.; Gila, A.; Sánchez Antolín, G.; Sousa, J.; Serra, M.; Diago, M.; Romero, M.; Fernandez, C.; Navarro, J.; López, M.; Testillano, M.; Andrade, R.; Granados, R.; Sanchez Ruano, J.; Gonzalez López, O.; Ortega, A.; Jimenez, F.; Prieto, M.

Book ID: 122226040
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 78 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61356-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1200 EFFECTIVENESS OF TRIPLE THERAPY WI

P1200 EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT

✍ Fernández, C.; Muñoz de Rueda, P.; Alonso, S.; Prieto, M.; Martín-Álvarez, A.; P 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Boceprevir (BOC) and Telaprevir (TPV) th

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment

✍ Chantry, AS; Tching-Sin, M; Dhiver, C; Allegre, T; Ruiz, JM; Assi, A; Botta-Frid 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 90 KB

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)

✍ Prieto, M.; Pascasio, J.; Vinaixa, C.; Gila, A.; Serra, M.; Ruiz Escolano, E.; C 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Su1292 A Week-8 Model Predicting Early V

Su1292 A Week-8 Model Predicting Early Virological Response (EVR) and Futility of Boceprevir (BOC) Based Triple Therapy Regimen in Treatment-Experienced Patients With Cirrhosis and Bridging Fibrosis: Results Fron the Real-Life Compasional (Romanian) Named Patients Program (NPP)

✍ Gheorghe, Liana S.; Iacob, Speranta; Caruntu, Florin A.; Simionov, Iulia I.; Mot 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB